New MAPP Gives Sponsors Seven Days to Correct Minor ANDA Deficiencies

Drug Industry Daily
The FDA published a new manual of policies and procedures for reviewing staff, detailing how the agency will communicate ANDA deficiencies with applicants — meeting one of its first commitments for the next generation of GDUFA.

To View This Article:


Subscribe To Drug Industry Daily